NHI.no
Annonse
Informasjon

Skjev penis - krummerik, Peyronies sykdom

Skjev penis er en unormal krumming av penis. Krummingen er best synlig ved ereksjon. Det skilles mellom medfødt krumning av penis og tilstanden induratio penis plastica, som utvikler seg i voksen alder.

Skjev penis gir hos de fleste med denne tilstanden ingen andre plager enn at penis er skjev.

Sist oppdatert:

26. mai 2022

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Skjev penis . Referanselisten for dette dokumentet vises nedenfor

  1. Svendsen K-OB, Schultz A. Seksuell dysfunksjon hos menn. Tidsskr Nor Legeforen 2008; 128: 448-52. Tidsskrift for Den norske legeforening
  2. Chung PH, Han TM, Rudnik B, Das AK. Peyronie's disease: what do we know and how do we treat it?. Can J Urol. 2020;27(S3):11-19. PMID: 32875997 PubMed
  3. Wan J, Rew KT. Common penile problems. Prim Care 2010; 37: 627-42. PubMed
  4. Mulhall JP, Alex B, Choi JM. Predicting delay in presentation in men with Peyronie's disease. J Sex Med 2010; 7: 2226-30. PubMed
  5. Ralph D, Gonzalez-Cadavid N, Mirone V, et al. The management of Peyronie's disease: evidence-based 2010 guidelines. J Sex Med 2010; 7: 2359-74. PubMed
  6. LaRochelle JC, Levine LA. A survey of primary care physicians and urologists regarding Peyronie`s disease. J Sex Med 2007; 4: 1167-73. PubMed
  7. Ziegelmann MJ, Bajic P, Levine LA. Peyronie's disease: Contemporary evaluation and management. Int J Urol. 2020;27(6):504-516. PubMed
  8. Serefoglu EC, Hellstrom WJ.. Treatment of Peyronie's disease: 2012 update. Curr Urol Rep 2011; 12: 444-52. PubMed
  9. Brant WO, Bella AJ, Lue TF. Peyronie's disease: Diagnosis and medical management. UpToDate, last updated Jul 26, 2021. www.uptodate.com
  10. Larsen SM, Levine LA. Review of non-surgical treatment options for Peyronie's disease. Int J Impot Res 2012; 24: 1-10. PubMed
  11. Larsen SM, Levine LA. Peyronie's disease: review of nonsurgical treatment options. Urol Clin North Am 2011; 38: 195-205. PubMed
  12. Gelbard M, Goldstein I, Hellstrom WJ, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol 2013; 190: 199-207. pmid:23376148 PubMed
  13. Nguyen HMT, Yousif A, Chung A, et al. Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute Phase Peyronie's Disease: A Multi-institutional Analysis. Urology 2020; 145:147. PubMed
  14. Russo GI, Milenkovic U, Hellstrom W et al. Clinical Efficacy of Injection and Mechanical Therapy for Peyronie's Disease: A Systematic Review of the Literature. Eur Urol 2018. pmid:30237020 PubMed
  15. Inal T, Tokatli Z, Akand M, et al. Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study. Urology 2006; 67: 1038-42. PubMed
  16. Russel S, Steers W, McVary KT. Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease. Eur Urol 2007; 51: 640. pmid:17092631 PubMed
  17. Kadioglu A, Küçükdurmaz F, Sanli O. Current status of the surgical management of Peyronie's disease. Nat Rev Urol 2011; 8: 95-106. PubMed
  18. Chung E, Clendinning E, Lessard L et al: Five-year follow-up of Peyronie’s graft surgery: outcomes and patient satisfaction. J Sex Med 2010; 8: 594. PubMed
  19. Palmieri A, Imbimbo C, Longo N, et al. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease. Eur Urol 2009; 56: 363-9. PubMed
  20. Greenfield JM, Shah SJ, Levine LA. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial. J Urol 2007; 177: 972-5. PubMed
  21. Vernet D, Nolazco G, Cantini L, et al. Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells: implications for peyronie disease. Biol Reprod 2005; 73: 1199-210. PubMed
  22. Mulhall JP, Schiff J, Guhring P. An analysis of the natural history of Peyronie's disease. J Urol 2006; 175: 2115-8. PubMed
  23. Chung E, Clendinning E, Lessard L, Brock G. Five-year follow-up of Peyronie's graft surgery: outcomes and patient satisfaction. J Sex Med 2011; 8: 594-600. PubMed
  24. Levine LA, Benson J, Hoover C. Inflatable penile prosthesis placement in men with Peyronie`s disease and drug-resistant erectile dysfunction. J Sex Med 2010; 7: 3775-83. PubMed
  25. Abdel-Hamid IA, Anis T. Peyronie's disease: perspectives on therapeutic targets. Expert Opin Ther Targets 2011; 15: 913-29. PubMed
  26. Jordan GH. The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study. J Sex Med 2008; 5: 180-7. PubMed
  27. European Medicines Agency. Summary of opinion: Xiapex - collagenase clostridium histolyticum. 18 December 2014. www.ema.europa.eu
  28. Soh J, Kawauchi A, Kanemitsu N, et al. Nicardipine vs. saline injection as treatment for Peyronie's disease: a prospective, randomized, single-blind trial. J Sex Med 2010; 7: 3743-9. PubMed
  29. Peyronie's Disease: Nonsurgical Therapy Options. Kuehhas FE, Weibl P, Georgi T, et al. Rev Urol 2011; 13: 139-46. PubMed
Annonse
Annonse